Osteoarthritis (OA) is one of the most
common causes of joint discomfort and disability.
Since its prevalence increases with age, the
global rise in the geriatric population portends an
increased burden of this disease on individuals
and the health care system. Hirudotherapy may
offer another therapeutic option to reduce the
pain and debility caused by OA. However,
additional studies with robust methodology
and adequate sample size are needed to better
evaluate whether hirudotherapy should be among
standard clinical practice for OA treatment.